Economy

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Buckles Under The Trend Lines

Another trade for 3,000 shares valued at $1.35M was sold by BROWN MICHAEL S. $1.35 million worth of stock was sold by STAHL NEIL on Thursday, June 1. Canaccord Genuity's target price suggests a potential upside of 13.02% from the stock's current price.

A number of other equities research analysts have also recently weighed in on the company. Piper Jaffray Companies restated an "overweight" rating and issued a $557.00 price target on shares of Regeneron Pharmaceuticals in a report on Tuesday, August 1st.

Investors and Traders continue to monitor technical levels of shares of Regeneron Pharmaceuticals, Inc. Leerink Swann reiterated a "positive" rating and issued a $552.00 price objective (down previously from $580.00) on shares of Regeneron Pharmaceuticals in a report on Tuesday, August 15th. The mean rating score for this stock is at 1.50. Finally, Vetr cut Regeneron Pharmaceuticals from a "strong-buy" rating to a "buy" rating and set a $419.76 target price for the company.in a research note on Monday, July 11th.

Among 10 analysts covering CDW (NASDAQ:CDW), 6 have Buy rating, 1 Sell and 3 Hold.

As the earnings date approaches, we can see that insider ownership is now 0.40% shares, and institutional ownership is at 72.20% for Regeneron Pharmaceuticals, Inc. In current trading day Smith & Nephew plc (SNN) stock confirmed the flow of -0.91% with the final price of $37.08. Regeneron Pharmaceuticals has a 12-month low of $325.35 and a 12-month high of $565.68.

REGN's insider meaningful buying activity tells us the shares are now in favour, which is fairly consistent with earnings growth expectations, although the share price has not moved significantly to warrant reassessment of mispricing. The company has a market capitalization of $43,570.81, a PE ratio of 38.22, a price-to-earnings-growth ratio of 1.40 and a beta of 1.56. If you are accessing this story on another website, it was illegally copied and republished in violation of United States & worldwide trademark & copyright legislation. Vanguard Group Inc. raised its holdings in shares of Regeneron Pharmaceuticals by 2.9% in the 2nd quarter. The biopharmaceutical company reported $3.13 earnings per share for the quarter, beating the Zacks' consensus estimate of $2.73 by $0.40. It has a return on equity (ROE) of 23.90%.

Revenues rose 23% from previous year to $1.5 billion, also topping analysts' view for $1.45 billion.

Net income increased to $388.3m, or $3.32 a share, from $264.8m, or $2.27 a share, in the same period a year ago. The company's revenue was up 7.3% on a year-over-year basis.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by American Banking News and is owned by of American Banking News.

TRADEMARK VIOLATION WARNING: This story was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. The correct version of this story can be accessed at https://weekherald.com/2017/11/08/regeneron-pharmaceuticals-inc-regn-receives-new-coverage-from-analysts-at-guggenheim.html.

In other news, Director Charles A. Baker sold 2,000 shares of Regeneron Pharmaceuticals stock in a transaction dated Friday, September 29th. The stock was sold at an average price of $450.00, for a total transaction of $956,250.00. Following the sale, the director now owns 11,000 shares of the company's stock, valued at $4,950,000. The purchase was disclosed in a filing with the SEC, which is available at this link. Shares for $710,694 were sold by LEAHY CHRISTINE A. 16,244 CDW Corp (NASDAQ:CDW) shares with value of $994,791 were sold by Richards Thomas E. Sterling Investment Advisors Ltd. now owns 278 shares of the biopharmaceutical company's stock worth $137,000 after buying an additional 28 shares in the last quarter.

Several hedge funds and other institutional investors have recently modified their holdings of REGN. VAGELOS P ROY also sold $4.26 million worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) on Thursday, May 25. Jennison Associates now owns 1,922,133 shares of the biopharmaceutical company's stock worth $894,061,000 after buying an additional 189,407 shares in the last quarter. FNY Partners Fund LP increased its holdings in shares of Regeneron Pharmaceuticals by 200.0% during the second quarter. A well-known argument is that insiders investing more in their own companies' shares sends an optimistic signal. Gerstein Fisher now owns 900 shares of the biopharmaceutical company's stock worth $419,000 after buying an additional 195 shares in the last quarter.



Like this

Latest


09 November 2017
Institutional Investor Sentiment About Sterling Capital Corp (NYSE:SPR) Up
Macquarie Group Ltd. boosted its position in shares of Spirit Aerosystems Holdings by 7.3% during the third quarter. (NYSE:SPR). Coliseum Capital Management Llc holds 5.21% of its portfolio in Advanced Emissions Solutions, Inc. for 931,808 shares.

09 November 2017
Most Active Stock: General Motors Company (GM)
Institutional investors have recently modified their holdings of the business. 76 funds opened positions while 292 raised stakes. Credit Suisse maintained the shares of NFLX in report on Monday, April 18 with "Neutral" rating. 166 are held by Jpmorgan Chase.

09 November 2017
American Equity Investment Life Holding Company - AEL - Stock Price Today
Apollo Management Holdings L.P. boosted its position in American Equity Investment Life Holding by 26.7% during the 2nd quarter. In addition to RBC Capital reporting its stock price target, a total of 6 brokers have issued a research note on the company.

09 November 2017
Newborn infant left in 'baby box' at in fire department
OH parents are not asked any questions if they choose to drop an infant off at a hospital police station or fire station. The box is offering parents who cannot care for their newborn an option to give their baby up, no questions asked.

09 November 2017
Proshare Advisors Boosted Exxon Mobil (XOM) Position; CSP (CSPI) Sentiment Is 0.5
Horan Securities Inc. purchased a new stake in shares of Exxon Mobil Corp. during the third quarter worth approximately $137,000. Following the completion of the sale, the vice president now owns 231,572 shares in the company, valued at $18,470,182.72.

09 November 2017
Voters in Kansas City Pass Measure for New Airport
Expected in the new airport are additional restaurants and increased waiting space, according to KCTV . They said the single terminal would be less secure and less convenient for travelers.

09 November 2017
Caitlyn Jenner Hasn't Spoken To Kim Kardashian In A Year
In an April appearance on The Ellen DeGeneres Show , Kim Kardashian West described Cait's depiction of Kris as deeply wounding. Caitlyn will be chatting about whether or not she'll be mending fences with Kim before the birth of her grandchild.

09 November 2017
Investors Trading Alert: Sandstorm Gold Ltd. (SAND), ARMOUR Residential REIT, Inc. (ARR)
Ever wonder how investors predict positive share price momentum? The Price Index 12m for Sandstorm Gold Ltd. (TSX:SSL) is 0.84651. The stock of Osisko gold royalties Ltd (TSE:OR) has "Buy" rating given on Wednesday, March 1 by Desjardins Securities.

09 November 2017
Gossip Girl star faces rape investigation by LA cops
The Hollywood Reporter says it has obtained a copy of the police report and verified it was filed by Cohen. Cohen writes that the producer "put the blame on me, telling me I was an active participant".

09 November 2017
Showtime Renews 'Shameless' for Season 9
Kev ( Steve Howey ) and V (Hampton) have to find a way to deal with Svetlana (Goreshter) after she steals their bar, The Alibi. Fiona (Rossum) faces hard decisions when she discovers her success as a landlord might mean someone else's misfortune.



Recommended